Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
9,069
+569
+7% +$118K 0.09% 124
2026
Q1
$1.91M Buy
8,500
+1,764
+26% +$440K 0.13% 110
2025
Q4
$1.62M Buy
6,736
+5,718
+562% +$1.46M 0.1% 121
2025
Q3
$279K Buy
1,018
+226
+29% +$61.7K 0.02% 415
2025
Q2
$204K Buy
+792
New +$189K 0.02% 401

Other funds holding RMD

Certuity's RMD Position: Q2 2026 in Review

Certuity increased its ResMed (RMD) stake by 6.7% in Q2 2026, buying an estimated $118K and bringing the position to 9,069 shares worth $1.77M. The position accounts for 0.09% of the portfolio, ranked #124.

Certuity first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.91M in Q1 2026. 271 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Certuity held 9,069 shares of ResMed worth $1.77M as of Q2 2026.
  • Certuity bought 569 ResMed shares in Q2 2026, an estimated $118K.
  • ResMed made up 0.09% of Certuity's portfolio in Q2 2026, its #124 holding.
  • Certuity first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • Certuity's ResMed position peaked at $1.91M in Q1 2026.
  • 271 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.